General contact

Main switchboard
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Investors

Investor Relations
Switzerland

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Stakeholder engagement

Our stakeholders include companies, governments, international agencies, foundations, customers and others. We must engage with these diverse groups to understand their needs and expectations, and to improve access to healthcare.

We work to identify the concerns of people who are central to our business, learn more about the needs of stakeholders and their opinion leaders, influence debates by presenting our position and develop coordinated action to overcome barriers to healthcare access.

Encouraging dialogue

Dialogue and networking are central to the activities of the Novartis Foundation for Sustainable Development (NFSD). In 2010, the NFSD started the Geneva dialogues, an event series to share and discuss new approaches to tackling global health challenges with a variety of stakeholders.

Two Geneva dialogues took place in 2011, focusing on the use of mobile technology in healthcare (m-health) and alliances for development and public health. Hosted by the NFSD in collaboration with the International Telecommunication Union, the Global Health Program of the Graduate Institute of International and Development Studies, and the Global Partnerships Forum, expert groups explored m-health solutions to improve access to healthcare services in developing countries and key characteristics of successful multi-stakeholder alliances.

In 2012, NFSD hosted two dialogues:

  • Psychosocial support for vulnerable children, including presentations from groups including the Swiss Academy for Development and REPSSI. Learn more
  • How to make leprosy history? Innovative stakeholder solutions to tackle the last mile. Learn more